EUVIMEDEUVIMED entdecken
Crossref

Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives

Kamil Kania, Artur Spyrka, Szymon Domagała, Jakub Nocoń, Mateusz Marcinek, Tomasz Lepich, Michał Tkocz

Journal of Sexual and Mental Health · 2026

DOI: 10.5603/jsmh.108924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sexual and Mental Health, 2026. Verfasst von Kamil Kania und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Between 2008 and 2011, the rate of unintended pregnancies decreased by approximately 18% in the USA, largely due to the wider use of effective, long-acting, reversible contraceptives among women, such as intrauterine devices and subdermal implants. Despite advances in female contraception, the development of safe and convenient male contraceptive methods remains a significant clinical challenge. Current clinical research focuses on two oral hormonal agents: dimethandrolone undecanoate (DMAU) and 11β-methylnortestosterone dodecylcarbonate (11β-MNTDC). These synthetic androgenic and progestagenic steroids inhibit gonadotropin secretion and spermatogenesis by suppressing key molecules of the hypothalamic–pituitary–gonadal axis. Phase I and IIa trials have shown that they effectively suppress luteinizing hormone, follicle-stimulating hormone, and testosterone to contraceptive levels and have favorable safety profiles and mild adverse effects (e.g., slight weight gain and minor libido changes), with 11β-MNTDC associated with relatively milder adverse effects. DMAU and 11β-MNTDC differ slightly in their metabolic effects and tolerability. Longer-term phase IIb and III clinical trials are required to confirm their efficacy, reversibility, and safety. Both agents have the potential to become the first reversible oral hormonal male contraceptive.

Zitieren

APA

Kania, K., Spyrka, A., Domagała, S., Nocoń, J., Marcinek, M., Lepich, T., & Tkocz, M. (2026). Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives. Journal of Sexual and Mental Health. https://doi.org/10.5603/jsmh.108924

Vancouver

Kania K, Spyrka A, Domagała S, Nocoń J, Marcinek M, Lepich T, et al. Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives. Journal of Sexual and Mental Health. 2026. doi:10.5603/jsmh.108924

BibTeX
@article{Kania2026,
  author = {Kania, Kamil and Spyrka, Artur and Domagała, Szymon and Nocoń, Jakub and Marcinek, Mateusz and Lepich, Tomasz and Tkocz, Michał},
  title = {Latest advances in oral hormonal male contraception: efficacy, mechanisms of action, and future perspectives},
  journal = {Journal of Sexual and Mental Health},
  year = {2026},
  doi = {10.5603/jsmh.108924}
}
Kostenlos starten →